This Metric Says You Are Smart to Buy Progenics Pharmaceuticals, Inc. (PGNX) – Cerus Corporation (CERS), XOMA Corp (XOMA)

Page 1 of 2

Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) investors should pay attention to an increase in support from the world’s most elite money managers recently.

Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX)

In the eyes of most shareholders, hedge funds are assumed to be underperforming, outdated financial tools of yesteryear. While there are more than 8000 funds trading at the moment, we choose to focus on the upper echelon of this club, around 450 funds. It is estimated that this group has its hands on most of the smart money’s total capital, and by keeping an eye on their best investments, we have identified a few investment strategies that have historically beaten the S&P 500 index. Our small-cap hedge fund strategy beat the S&P 500 index by 18 percentage points per year for a decade in our back tests, and since we’ve began to sharing our picks with our subscribers at the end of August 2012, we have outclassed the S&P 500 index by 24 percentage points in 7 months (check out a sample of our picks).

Just as key, bullish insider trading activity is a second way to break down the financial markets. Just as you’d expect, there are plenty of reasons for a corporate insider to cut shares of his or her company, but only one, very obvious reason why they would buy. Several academic studies have demonstrated the useful potential of this strategy if shareholders understand what to do (learn more here).

Now, let’s take a gander at the key action surrounding Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX).

What does the smart money think about Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX)?

In preparation for this year, a total of 9 of the hedge funds we track held long positions in this stock, a change of 29% from one quarter earlier. With hedge funds’ capital changing hands, there exists a select group of notable hedge fund managers who were boosting their stakes substantially.

When looking at the hedgies we track, Broadfin Capital, managed by Kevin Kotler, holds the biggest position in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). Broadfin Capital has a $11 million position in the stock, comprising 2.7% of its 13F portfolio. Sitting at the No. 2 spot is Tudor Investment Corp, managed by Paul Tudor Jones, which held a $7 million position; the fund has 0.2% of its 13F portfolio invested in the stock. Remaining peers that hold long positions include James E. Flynn’s Deerfield Management, Julian Baker and Felix Baker’s Baker Bros. Advisors and Cliff Asness’s AQR Capital Management.

With a general bullishness amongst the heavyweights, some big names were breaking ground themselves. Broadfin Capital, managed by Kevin Kotler, assembled the largest position in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). Broadfin Capital had 11 million invested in the company at the end of the quarter. James E. Flynn’s Deerfield Management also initiated a $4 million position during the quarter. The other funds with brand new PGNX positions are Julian Baker and Felix Baker’s Baker Bros. Advisors and Ben Levine, Andrew Manuel and Stefan Renold’s LMR Partners.

How have insiders been trading Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX)?

Insider buying is at its handiest when the company in focus has experienced transactions within the past half-year. Over the last half-year time period, Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) has seen 1 unique insiders buying, and zero insider sales (see the details of insider trades here).

Let’s also take a look at hedge fund and insider activity in other stocks similar to Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). These stocks are XOMA Corp (NASDAQ:XOMA), Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY), Curis, Inc. (NASDAQ:CRIS), Cerus Corporation (NASDAQ:CERS), and Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS). This group of stocks are in the biotechnology industry and their market caps match PGNX’s market cap.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

50 Crazy Facts About Japan You Won’t Believe

Top 10 Least Expensive Hybrid Cars to Save the Planet With

The 10 Biggest ‘Gate’ Controversies in History

The 10 States with the Highest Nursing Shortages Leaving Their Hospitals Depleted

The 10 Best Value Investment Blogs that Every Investor Must Read

The 6 Cheapest Boarding Schools in Europe 2015

The 5 Most Expensive Cars To Insure in the World

The 10 Most Common Genetically Modified Foods

10 Self-Made Billionaires Who Came From Nothing

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays

The 10 Healthiest Fast Food Chains in America to Dine At

The 5 Most Expensive Cat Food Brands You Can Spoil Your Kitty With

The 6 Best eCommerce Platforms for Small Businesses

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!